OMER · Omeros Corp
United States · RS rating 92 · As of 2026-11-03
| Price | 18.27 USD |
|---|---|
| 1-day change | +2.5% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 48 / 94 / 96 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 50 / 46 / 71 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +308.5% |
| Sales growth Q/Q | +188.4% |
| Distance from 52-week high | +13.2% |
| Market cap (USD) | $973.4M |